The present study was designed to define the phenolic content, antioxidant and anti-inflammatory activity of Crateagus orientalis Pall. ex M. Bieb., traditionally used by local people in southern parts of F.Y.R. Macedonia. The presence and content of 7 phenolics in ethanolic extracts of leaves and berries were studied using HPLC-DAD, where the most dominant compounds were hyperoside, isoquercitrin and chlorogenic acid. The leaf extract was more effective as a DPPH radical scavenger (IC 50 = 29.7 µg/g) than the berry extract, as well as in the relative reducing power on Fe 3+ . Anti-inflammatory potential was studied by means of cyclooxygenase-1 (COX-1) and 12-lipoxygenase (12-LOX) inhibitory activity; both extracts evinced activity. Furthermore, C. orientalis leaf extract showed a concentration dependent inhibition of COX-1 pathway products 12-HHT and TXB 2 , reaching IC 50 values below the lowest applied concentration (68.9% and 55.2% of 12-HHT and TXB 2 production inhibition, respectively, at concentration of 0.4 mg/mL). Although inhibitors such as acetylsalicylic acid and quercetin showed higher activity, this study demonstrates that the investigated extracts are potential anti-inflammatory agents.
Medicinal use of extracts prepared from the leaves, flowers, and fruits of hawthorn (Crataegus spp., Rosaceae) dates back to ancient times. The plant is still a popular herbal medicine, widely used in traditional as well as in official medicine for preventing and treating cardiovascular diseases including angina, hypertension, arrhythmias, and congestive heart failure [1, 2] . Hydroalcoholis extracts of Crataegus species have been found to possess hypocholesterolemic effect [3] and to inhibit angiotensin-converting enzyme [4] . The main secondary metabolites of hawthorn are flavonoids, proanthocyanidins, anthocyanins, organic and phenolic acids. Terpenes, lignans, phenylpropanoids, hydroxycinnamic acids and even essential oils have been reported [2] . Flavonoids and oligomeric proanthocyanidins are considered to be most important for pharmacological activity [3] . Different Crataegus species have been used as herbal medicines in many countries, including species that are official in the European Pharmacopoeia 7.0 [5] , such as C. monogyna and C. oxyacantha. On the other hand, the usage of C. orientalis has been reported only in a few Middle East ethnobotanical surveys [6, 7] . A recent ethnobotanical study locates the usage of C. orientalis in southern parts of F.Y.R. Macedonia (unpublished data). Thus, studies on C. orientalis are scarce, compared to other Crayaegus species.
The flavonoid content of leaves, flowers and unripe fruits of C. orientalis were investigated by Melikoglu et al. [8] ; apigenin, apigenin-7-glucoside, hyperoside, vitexin and vitexin-4'-rhamnoside were isolated from the leaves, apigenin, quercetin, hyperoside, vitexin 4'-rhamnoside and rutin from the flowers, and apigenin, quercetin, hyperoside and rutin from the fruits. Arslana et al. [9] indicated that the ethanol extract of C. orientalis leaves suppress the formation of thrombosis in the carrageenan-induced mice tail thrombosis model and that it could be a good candidate for the development of a new antithrombotic medicine. Furthermore, Bor et al. [10] showed that the ethanol extract of C. orientalis leaves exhibits remarkable antinociceptive, antiinflammatory, and antioxidant activities.
To the best of our knowledge, the chemical composition of C. orientalis originating from the Balkan Peninsula has not been investigated till now and since the biological potency of this species is not investigated sufficiently, the aim of our study was to investigate the polyphenolic profile, and the antioxidant and antiinflammatory activity of leaves and fruits of C. orientalis native to the southern parts of F.Y.R. Macedonia.
The total phenolic content of extracts of C. orientalis leaves and berries varied from 77.4 to 94.2 mg GAE/g of dry extract (Table 1) ; the leaves contained higher phenolic content than the berries. Our results pointed out greater phenolics accumulation in Balkan growing C. orientalis compared with several hawthorn species from Turkey where the phenolic content of methanol extracts of berries ranged from 35.7 to 55.2 mg GAE/g dry weight [11] . On the other hand, a high value for total phenolic content (343.5 mg GAE/g) in the ethyl acetate extract of C. monogyna leaves was reported by Öztürk et al. [12] . Park et al. [13] studied the ethyl acetate fraction of hawthorn berries, which were also characterized by high phenolic and flavonoid contents (140.2 tannic mg/g and 56.5 catechin mg/g, respectively). Literature data show significant differences in total phenolic content of hawthorn, probably due to several factors such as natural habitat, genotype, growth stage, extraction procedure and method for determination of total phenolics.
Previous studies have shown that the polyphenolic profile of hawthorn fruits and leaves were different and depended on the growth stage [14] . Few reports indicated that the flavonoids were the major markers for the interspecific distinction between NPC Natural Product Communications Crataegus species [15] . Our study presents the phenolic composition of the methanol extracts of C. orientalis leaves and fruits analyzed by HPLC-DAD at 280 nm and 360.
Identification of seven compounds (chlorogenic acid, epicatechin, vitexin, rutin, hyperoside, isoquercitrin and quercetin) was made by comparison of their retention times and UV spectra with pure standards.
The results of quantitative analyses are shown in Table 1 .
The main compounds of the tested extracts were two O-glycosylflavones, hyperoside and isoquercitrin. Higher content of these flavonoids (12.9 mg/g DW and 10.4 mg/g DW, respectively) was found in the methanol extract of C. orientalis leaves. Leaves were also characterized by high amounts of chlorogenic acid and epicatechin, unlike in the berries. HPLC analysis of C. orientalis showed similarity with previously published results for C. monogyna collected in Serbia [16] and hawthorn species collected in Turkey and China [11, 17] . Hyperoside was found to be the main flavonoid in the leaves and flowers of C. tanacetifolia, C. orientalis, C. stevenii and C. microphylla [18] . Liu et al. [17] also showed that hyperoside and isoquercitrin are the most abundant flavonol glycosides in the extracts of Chinese hawthorn berries. Polyphenols are known to be potent antioxidants and radical scavengers [19, 20] . Some Crataegus constituents are good antioxidants, among them hyperoside, quercetin, epicatechin, and chlorogenic acid. They are also good antilipoperoxidants [21, 22] . DPPH scavenging activity of the investigated methanol extracts are presented in Table 1 . The leaf extract was a more effective DPPH radical scavenger (IC 50 = 29.7 µg/g) than that of the berries (IC 50 = 111.9 µg/g). This strong antioxidant activity is associated with high total phenolic content and structural characteristics of the most abundant compounds hyperoside and isoquercitrin. The berries extract exhibited lower antioxidant activity probably due to considerably lower amounts of hyperoside, isoquercitrin, chlorogenic acid, and epicatechin. Remarkable antioxidant activity of a C. orientalis ethanolic extract was also reported by Bor et al. [10] using in vivo tests. Reducing power on Fe 3+ is one of the most frequently used tests for evaluation of the antioxidant potential of phytochemicals. Figure 1 shows the reducing power activity of methanol extracts of C. orientalis leaves and berries as a function of their concentrations. Trolox was used as a positive control. The reducing ability was found to be dosedependent. The relative reducing power of hawthorn extracts on Fe 3+ was higher for leaves of C. orientalis than for berries. Like the radical scavenging activity, the reducing power is also influenced by phenolic composition of these extracts.
Anti-inflammatory potential of methanol extracts of C. orientalis leaves and berries was determined using the intact cell system (platelets) as a source of cyclooxygenase-1 (COX-1) and 12-lipoxygenase (12-LOX) enzymes and a highly sensitive and specific LC-MS/MS technique for detection of the main arachidonic acid metabolites formed by them. Explicitly, 12-HHT (12(S)-hydroxy(5Z,8E,10E)-heptadecatrienoic acid), TXB 2 (thromboxane B2) and PGE 2 (prostaglandin E 2 ) are inflammation mediators derived from arachidonic acid metabolism, which is catalyzed by COX-1 enzyme, while 12-HETE (12(S)-hydroxy-(5Z,8Z,10E,14Z)-eicosatetraenoic acid) is a product of a 12-LOX pathway inflammatory response. The results of the inhibition potential of C. orientalis extracts, as well as of the known antiinflammatory agents aspirin and quercetin are shown in Table 2 . C. orientalis leaves extract showed concentration-dependent inhibition of COX-1 pathway products 12-HHT and TXB 2 , reaching IC 50 values below the lowest applied concentration (68.9% and 55.2% of 12-HHT and TXB 2 production inhibition, respectively, at a concentration of 0.4 mg/mL). Lower, but also significant inhibitory activity towards production of the same metabolites was also achieved by C. orientalis berries extract. Previously, it has been reported that C. oxycantha tincture and its isolated flavonoids inhibit the formation of potent inflammatory and platelet aggregation mediator TXA 2 an unstable metabolite which is hydrolyzed within about 30 seconds to TXB 2 [23] . Taking into account the TXB 2 inhibition potential of C. orientalis extracts determined in our study, some attention should be drawn to Crataegus species as a possible inhibitor of TXA 2 synthase. Since TXA 2 synthase is an enyzme that follows COX-1 in the formation of TXA 2 , a possible target for moderating inflammation by Crataegus species could be this point of arachidonic acid metabolism. Inhibition of PGE 2 production by C. orientalis was not concentration-dependent. In contrast, both examined extracts showed potential of 12-LOX inhibition. This finding could lead to meaningful studies of cytotoxic activity, because it was found that 12-HETE is also involved in the progression of various cancers [24] . Generally, the obtained results are in accordance with previously reported in vivo anti-inflammatory activity of C. orientalis collected in Turkey [8] . Overall, better activity of C. orientalis leaf extracts could be, at least partially, ascribed to higher content of phenolics than in berries. Particularly, the synthesis of compounds in the COX-1 and 12-LOX pathways, which go through radical reactions [25] might be terminated by phenolics. The
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Natural Product Communications Vol. 12 (2) 2017 161 determined COX-1 and 12-LOX pathway inhibition potential of C. orientalis extracts was significantly lower than the activity of a well-known potent inhibitor of COX-1, aspirin and 12-LOX, quercetin. On the other hand, the achieved range of extract activities is indisputably comparable with that of some species traditionally used and well-known as anti-inflammatory agents [26] .
In the present study, C. orientalis leaves and berries were investigated for their chemical composition, antioxidant and antiinflammatory activity. This species showed notable phenolic content with hyperoside, isoquercitrin and chlorogenic acid as dominant compounds. Both extracts showed DPPH radical scavenging activity where leaves were more effective due to a high total phenolic content. Relative reducing power on Fe 3+ was also higher for leaves of C. orientalis. Anti-inflammatory potential was shown by inhibition of cyclooxygenase-1 (COX-1) and 12-lipoxygenase (12-LOX) enzymes. Thus, C. orientalis leaves and berries may be considered as a significant therapeutic source. Extraction procedure: Collected leaves and berries of C. orientalis were air dried, ground and extracted in a Soxhlet apparatus for 72 h with 96% ethanol. The amount for extraction was: leaves 28.2 g and berries 38.1 g. Extracts were evaporated under vacuum at 40 o C and were used for further analysis. The yields of the extracts were as follow: leaves 8.5 g, berries 15.5 g. Prior to HPLC analysis, the dry extracts of leaves (20 mg) and berries (50 mg) were dissolved in methanol (1 mL) and filtered through 0.45 μm membrane filters.
Experimental

Total phenolic content:
The content of total phenolics was determined according to the Folin-Ciocalteu colorimetric method, with some modification [27] . In brief, a methanol solution of extract (100 μL) was oxidized with Folin-Chiocalteu reagent (500 μL, previously diluted 10-fold with distilled water). The reaction was neutralized with saturated sodium carbonate (400 μL, 75 g/L). After 2 h of incubation at room temperature, absorbance was measured by an UV-Visible spectrophotometer (Agilent 8453) at 765 nm. Quantification was performed based on the standard curve of gallic acid and results were expressed as mg of gallic acid equivalents (GAE) per g dry weight of extract (DW).
Quantification of polyphenols:
Phenolic acids and flavonoids were quantified by high-performance liquid chromatography using an Agilent 1100 chromatograph equipped with a DAD detector. HPLC analysis was performed with an Agilent Zorbax SB-C18 analytical column (250 mm x 4.6 mm, 5 µm particle size). The mobile phase consisted of solvent A (1%, v/v, orthophosphoric acid in water) and solvent B (acetonitrile), using gradient elution as follows: 10% B 0 min, 10-25% B 0-30 min, 25-55% B 30-40 min, 55-100% B 40-50 min, 100% B 50-55 min. Detection wavelengths were set at 280 and 360 nm, and the solvent flow rate was 0.8 mL/min. The amounts of the compounds were calculated using calibration curves of standards. The results were expressed as mg per g dry weight of extract.
Reducing power:
The reducing power of the tested extracts was evaluated according to the method described by Li et al. [28] , with several modifications. The methanol solution of extracts (200 µL, 0.1-1 mg/mL) was mixed with phosphate buffer (500 µL, 0.2 mM, pH=7) and potassium ferricyanide (400 µL, 10 mg/mL). After incubation at 50°C for 20 min, trichloroacetic acid (500 µL, 100 mg/mL) was added and the mixture was centrifuged at 2000 × g for 10 min. The supernatant (500 µL) was mixed with distilled water (500 µL) and FeCl 3 (100 µL, 1 mg/mL), and the mixture was left to stand for 10 min at room temperature. Finally the absorbance of solution was measured by an UV-Visible spectrophotometer (Agilent 8453) at 700 nm. Trolox was used as a positive control. The increased absorbance indicated increased reducing power.
Free radical scavenging activity: The free radical scavenging activity of the fractions was analyzed using the DPPH assay following a method described by Brand-Williams et al. [29] . The reaction mixture (1 mL) contained 500 µL of daily prepared DPPH solution (150 µM) and 500 µL of various concentrations (0.03, 0.06, 0.125, 0.25 and 0.5 mg/mL) of the tested extracts dissolved in methanol. After vortex mixing, the solutions were kept in the dark for 20 min at room temperature. Thereafter, the absorbance was measured at 517 nm. Trolox and ascorbic acid were used as positive controls. The percent inhibition was calculated against the control solution containing methanol instead of test solution.
Anti-inflammatory activity:
Ex vivo COX-1 and 12-LOX assay was undertaken according to the method previously described [30] . An aliquot of human platelet concentrate, viable, but outdated for medical treatment, which contained 4 × 108 cells was suspended in buffer (0.137 mol/L NaCl, 2.7 mmol/L KCl, 2.0 mmol/L KH 2 PO 4 , 5.0 mmol/L Na 2 HPO 4 and 5.0 mmol/L glucose, pH 7.2) to obtain a final volume of 2 mL. This mixture was slowly stirred at 37°C for 5 min. Subsequently, 0.1 mL of either extracts or standard compound solutions in DMSO (concentration ranging from 10.0 to 300.0, 0.156 to 5.0 and 0.01 to 0.6 mg/mL for extracts, quercetin and aspirin, respectively) and 0.1 mL of calcimycin (125 µmol/L in DMSO) were added and incubated for 2 min at 37°C, with moderate shaking. The exact amount of extract in control and calcimycin in blank probe were substituted with solvent (DMSO). Thereafter, 0.3 mL of CaCl 2 aqueous solution (16.7 mmol/L), substituted with water in a blank probe, was added and the mixture was incubated for a further 5 min at 37°C with shaking. Acidification with cold 1% aqueous formic acid (5.8 mL) to pH 3 terminated the reaction. If gel formation occurred, vortexing was applied before mixing with the acid. Internal standard PGB 2 (50 µL of 6 µg/mL solution in DMSO) was added and the mixture extracted with chloroform and methanol (1:1, 8.0 mL) with vigorous vortexing for 15 min. After centrifugation at 7012 × g for 15 min at 4°C, the organic layer was separated, evaporated to dryness, dissolved in methanol (0.5 mL), filtered and used for further LC-MS/MS analysis, previously described by Beara et al. [26] . The percent of COX-1 and 12-LOX inhibition achieved by different concentrations of extract was calculated by the following equation: I(%)=100×(R 0 −R)/R 0 , where R 0 and R were response ratios (metabolite peak area/internal standard peak area) in the control reaction and in the examined samples, respectively. Both R and R 0 were corrected for the value of the blank probe. Corresponding inhibition-concentration curves were drawn using Origin 8.0 software and IC 50 values (concentration of extract that inhibited COX-1 and 12-LOX metabolites formation and cell growth by 50%) were determined.
Statistical analysis:
For each assay and extract composition determinations, all the results were expressed as mean±standard deviation of 3 different measurements. A comparison of the group means and the significance between the groups were verified by one-way ANOVA followed by post-hoc Duncan's multiple range test. Level of statistical significance was set at P<0.05. 
